Attendance and diagnostic yield of repeated two-sample faecal immunochemical test screening for colorectal cancer
Objective: Limited data exist on attendance and additional yield of 2-sample faecal immunochemical testing (FIT) screening during multiple rounds. We therefore conducted a population-based colorectal cancer screening trial comparing attendance and yield of repeated 1-sample and 2-sample FIT screenin...
| Main Authors: | Kapidzic, A., van Roon, A., van Leerdam, M., van Vuuren, A., van Ballegooijen, M., Lansdorp-Vogelaar, Iris, Spijker, W., Izelaar, K., Hol, L., Kuipers, E. |
|---|---|
| Format: | Journal Article |
| Published: |
2015
|
| Online Access: | http://hdl.handle.net/20.500.11937/49863 |
Similar Items
Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
by: Goede, S., et al.
Published: (2013)
by: Goede, S., et al.
Published: (2013)
Gender Differences in Fecal Immunochemical Test Performance for Early Detection of Colorectal Neoplasia
by: Kapidzic, A., et al.
Published: (2015)
by: Kapidzic, A., et al.
Published: (2015)
A randomised comparison of two faecal immunochemical tests in population-based colorectal cancer screening
by: Grobbee, E., et al.
Published: (2016)
by: Grobbee, E., et al.
Published: (2016)
Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening
by: Wilschut, J., et al.
Published: (2011)
by: Wilschut, J., et al.
Published: (2011)
Adherence to colorectal cancer screening: Four rounds of faecal immunochemical test-based screening
by: Van Der Vlugt, M., et al.
Published: (2017)
by: Van Der Vlugt, M., et al.
Published: (2017)
Immunochemical faecal occult blood testing to screen for colorectal cancer: Can the screening interval be extended?
by: Haug, U., et al.
Published: (2016)
by: Haug, U., et al.
Published: (2016)
Do men and women need to be screened differently with fecal immunochemical testing? A cost-effectiveness analysis
by: Van Der Meulen, M., et al.
Published: (2017)
by: Van Der Meulen, M., et al.
Published: (2017)
Faecal immunochemical tests versus guaiac faecal occult blood tests: What clinicians and colorectal cancer screening programme organisers need to know
by: Tinmouth, J., et al.
Published: (2015)
by: Tinmouth, J., et al.
Published: (2015)
Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing
by: van der Vlugt, M., et al.
Published: (2017)
by: van der Vlugt, M., et al.
Published: (2017)
Nonbleeding adenomas: Evidence of systematic false-negative fecal immunochemical test results and their implications for screening effectiveness - A modeling study
by: Van Der Meulen, M., et al.
Published: (2016)
by: Van Der Meulen, M., et al.
Published: (2016)
Second-Look Colonoscopies and the Impact on Capacity in FIT-Based Colorectal Cancer Screening
by: Grobbee, E., et al.
Published: (2015)
by: Grobbee, E., et al.
Published: (2015)
Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
by: Goede, S., et al.
Published: (2017)
by: Goede, S., et al.
Published: (2017)
Optimisation of Faecal Immunochemical Test (FIT) for symptomatic colorectal cancer diagnosis
by: Bailey, James Alexander
Published: (2024)
by: Bailey, James Alexander
Published: (2024)
Fecal immunochemical test-based colorectal cancer screening: The gender dilemma
by: Grobbee, E., et al.
Published: (2017)
by: Grobbee, E., et al.
Published: (2017)
Fecal occult blood testing when colonoscopy capacity is limited
by: Wilschut, J., et al.
Published: (2011)
by: Wilschut, J., et al.
Published: (2011)
How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?
by: Wilschut, J., et al.
Published: (2011)
by: Wilschut, J., et al.
Published: (2011)
Colorectal cancer screening in Australia
by: Kuipers, E., et al.
Published: (2017)
by: Kuipers, E., et al.
Published: (2017)
Developing a score chart to improve risk stratification of patients with colorectal adenoma
by: Van Heijningen, E., et al.
Published: (2016)
by: Van Heijningen, E., et al.
Published: (2016)
Contribution of screening and survival differences to racial disparities in colorectal cancer rates
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)
Should colorectal cancer screening be considered in elderly persons without previous screening?: A cost-effectiveness analysis
by: Van Hees, F., et al.
Published: (2014)
by: Van Hees, F., et al.
Published: (2014)
The value of models in informing resource allocation in colorectal cancer screening: The case of the Netherlands
by: Van Hees, F., et al.
Published: (2015)
by: Van Hees, F., et al.
Published: (2015)
State disparities in colorectal cancer rates: Contributions of risk factors, screening, and survival differences
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2015)
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2015)
The impact of stratifying by family history in colorectal cancer screening programs
by: Goede, S., et al.
Published: (2015)
by: Goede, S., et al.
Published: (2015)
Optimal colorectal cancer screening in states' low-income, uninsured populations - The case of South Carolina
by: Van Der Steen, A., et al.
Published: (2015)
by: Van Der Steen, A., et al.
Published: (2015)
Colorectal cancer deaths attributable to nonuse of screening in the United States
by: Meester, R., et al.
Published: (2015)
by: Meester, R., et al.
Published: (2015)
A systematic comparison of microsimulation models of colorectal cancer: The role of assumptions about adenoma progression
by: Kuntz, K., et al.
Published: (2011)
by: Kuntz, K., et al.
Published: (2011)
The Impact of Uncertainty in Barrett's Esophagus Progression Rates on Hypothetical Screening and Treatment Decisions
by: Kroep, S., et al.
Published: (2015)
by: Kroep, S., et al.
Published: (2015)
Cost-effectiveness of colorectal cancer screening
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2011)
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2011)
Cost-savings to medicare from pre-medicare colorectal cancer screening
by: Goede, S., et al.
Published: (2015)
by: Goede, S., et al.
Published: (2015)
Validation of Models Used to Inform Colorectal Cancer Screening Guidelines
by: Rutter, C., et al.
Published: (2015)
by: Rutter, C., et al.
Published: (2015)
The appropriateness of more intensive colonoscopy screening than recommended in medicare beneficiaries: A modeling study
by: Van Hees, F., et al.
Published: (2014)
by: Van Hees, F., et al.
Published: (2014)
Clarifying differences in natural history between models of screening: The case of colorectal cancer
by: Van Ballegooijen, M., et al.
Published: (2011)
by: Van Ballegooijen, M., et al.
Published: (2011)
Variation in adenoma detection rate and the lifetime benefits and cost of colorectal cancer screening: A microsimulation model
by: Meester, R., et al.
Published: (2015)
by: Meester, R., et al.
Published: (2015)
Colorectal cancer screening using immunochemical fecal occult blood test
by: Tan, Mun Chieng, et al.
Published: (2017)
by: Tan, Mun Chieng, et al.
Published: (2017)
European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition Introduction
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2012)
Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths
by: Zauber, A., et al.
Published: (2012)
by: Zauber, A., et al.
Published: (2012)
Family history and the natural history of colorectal cancer: Systematic review
by: Henrikson, N., et al.
Published: (2015)
by: Henrikson, N., et al.
Published: (2015)
Calibrating Parameters for Microsimulation Disease Models
by: Van Der Steen, A., et al.
Published: (2015)
by: Van Der Steen, A., et al.
Published: (2015)
Features of adenoma and colonoscopy associated with recurrent colorectal neoplasia based on a large community-based study
by: Van Heijningen, E., et al.
Published: (2013)
by: Van Heijningen, E., et al.
Published: (2013)
Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: Study design
by: Rigter, L., et al.
Published: (2017)
by: Rigter, L., et al.
Published: (2017)
Similar Items
-
Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
by: Goede, S., et al.
Published: (2013) -
Gender Differences in Fecal Immunochemical Test Performance for Early Detection of Colorectal Neoplasia
by: Kapidzic, A., et al.
Published: (2015) -
A randomised comparison of two faecal immunochemical tests in population-based colorectal cancer screening
by: Grobbee, E., et al.
Published: (2016) -
Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening
by: Wilschut, J., et al.
Published: (2011) -
Adherence to colorectal cancer screening: Four rounds of faecal immunochemical test-based screening
by: Van Der Vlugt, M., et al.
Published: (2017)